166 related articles for article (PubMed ID: 38560562)
1. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract][Full Text] [Related]
2. IL-17 induces non-small cell lung cancer metastasis via GCN5-dependent SOX4 acetylation enhancing MMP9 gene transcription and expression.
Ge W; Gong Y; Li Y; Wu N; Ruan Y; Xu T; Shu Y; Qiu W; Wang Y; Zhao C
Mol Carcinog; 2023 Sep; 62(9):1399-1416. PubMed ID: 37294072
[TBL] [Abstract][Full Text] [Related]
3. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.
Yu G; Herazo-Maya JD; Nukui T; Romkes M; Parwani A; Juan-Guardela BM; Robertson J; Gauldie J; Siegfried JM; Kaminski N; Kass DJ
Am J Respir Crit Care Med; 2014 Oct; 190(7):780-90. PubMed ID: 25250855
[TBL] [Abstract][Full Text] [Related]
6. IL-17 promoted metastasis of non-small-cell lung cancer cells.
Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
[TBL] [Abstract][Full Text] [Related]
7. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
9. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
11. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
12. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
Zheng X; Xu M; Yao B; Wang C; Jia Y; Liu Q
Cell Signal; 2016 Sep; 28(9):1314-1324. PubMed ID: 27297362
[TBL] [Abstract][Full Text] [Related]
13. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
[TBL] [Abstract][Full Text] [Related]
14. EPN3 plays oncogenic role in non-small cell lung cancer by activating the JAK1/2-STAT3 pathway.
Meng J; Zhang C; Zhu N; Zhang C; Liu M; Han Z; Li Y
Environ Toxicol; 2023 Aug; 38(8):1968-1979. PubMed ID: 37186036
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.
Liu YS; Hsu JW; Lin HY; Lai SW; Huang BR; Tsai CF; Lu DY
Neuropharmacology; 2019 Jan; 144():143-154. PubMed ID: 30366000
[TBL] [Abstract][Full Text] [Related]
16. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
17. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
18. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
[TBL] [Abstract][Full Text] [Related]
19. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
20. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.
Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J
Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
